Wellcome Early-Career Awards 2026

MODERATE Tx Neuropharm/CCT

Strategy Notes

Eniola's strong early-career research record in computational neuroscience and pharmacology aligns with Wellcome's scope. However, Wellcome typically requires institutional affiliation; Eniola's current independent status plus upcoming MSc enrollment (Oct 2026) may create eligibility gaps. Full scheme details and residency/institution requirements needed.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: up to £400,000 research expenses + salary support
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · Applications must be administered through an eligible not-for-profit institution (university, research institute, or healthcare organisation) located in the UK, Republic of Ireland, or an eligible LMIC. Eniola is an independent researcher with no current institutional affiliation; with 12 days remaining until the 21 July 2026 (15:00 BST) deadline, securing a sponsoring host institution in time is not feasible. A compounding blocker is the absence of a PhD: the alternative '4+ years of equivalent research experience' pathway requires documented formal research training — her ~1–2 years of independent work (2025–2026) does not satisfy this threshold under Wellcome's standard interpretation.